Episode 62: Advanced Therapeutics in Parkinson and Movement Disorders
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Yasar Torres-Yaghi, MD. [LISTEN TIME: 25 minutes]
Episode 62 of the NeurologyLive
The Mind Moments® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 62, "Advanced Therapeutics in Parkinson and Movement Disorders," features an exclusive interview with Yasar Torres-Yaghi, MD, director, Parkinsonism and Dementia Clinic, assistant professor of neurology, MedStar Georgetown University Hosptial, about the current state of therapeutic intervention for movement disorders, and this year's first annual Advanced Therapeutics in Movement & Related Disorders™ Congress, being put on by the PMD Alliance.
The stories highlighted in this episode's Neurology News Minute can be found here:
FDA Approves Boston Scientific’s STIMVIEW XT Guided Imaging Software for DBS FDA Extends Review of Vutrisiran for ATTR Amyloidosis 3 Months, Now Expected in July 2022 Higher-dose Erenumab Shows Better Prevention of Progression, Rationale Provided for Initiation at High Dose
EPISODE BREAKDOWN
3:15 – Background on the new ATMRD Congress.
6:20 – Rates of adoption of novel therapeutics for Parkinson disease.
9:35 – What attendees should expect from the Congress this year.
11:20 – The need for a multidisciplinary approach to movement disorders and the multidisciplinary features of the Congress.
12:35 – Neurology News Minute
16:30 – Education and understanding about the optimal utilization of advanced therapies in Parkinson disease.
19:10 – Ongoing trends and conversations in the movement disorder field.
21:30 – Closing thoughts.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Current Challenges and New Opportunities Ahead for Women in NeurologySeptember 15th 2025
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial UpdateSeptember 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
This Week on NeurologyLive® — September 15, 2025September 15th 2025
